Selectivity comes from requiring two matched binding events rather than relying on a single recognition step. The immobilized capture antibody must bind the target, and the labeled detection antibody must recognize another site on that same molecule. Only targets that satisfy both conditions generate the assay signal, which helps distinguish the intended analyte from other substances.
Recognition of a different site on the analyte is central to the format's specificity. It allows the detection antibody to bind after capture without representing the same binding event. Because signal depends on both antibody-target interactions, the assay links detection to a target that has been independently recognized by the capture antibody.
The measured signal reflects the amount of target present because the signal increases as more analyte is captured and recognized. This relationship makes the format suitable for measurement rather than simple presence-or-absence detection. In practice, the resulting signal can be used to quantify proteins, hormones, cytokines, and other biomarkers identified by the assay.
A basic workflow begins with an immobilized capture antibody, followed by exposure to the analyte and recognition by a labeled detection antibody at a separate site. The assay then uses the resulting label-derived signal for measurement. Keeping these roles distinct preserves the two-event recognition scheme that gives the format its high specificity.
Sandwich Binding Format is especially useful when the target is a protein, hormone, cytokine, or another biomarker that can be recognized at two sites. Its output is a measurement of target amount, so the method can support experiments that require quantitative biomarker data rather than merely identifying that a binding reaction occurred.
Applications span biological research, clinical testing, and diagnostic assay development. In research, the format can quantify selected biomolecules; in clinical or diagnostic settings, the same two-antibody recognition principle supports measurement of biomarkers. The specific target and antibody pair determine what the assay measures, while the signal provides the reported analytical outcome.